The CNPV program leveraged to push groundbreaking results of gene therapy treatment. The Food and Drug Administration (FDA) has announced approval for Otarmeni (lunsotogene parvec-cwha), a first-of-its-kind treatment…
Read MoreGene Editing
NIH Research Discovers Gene-Editing Option for Disease Treatment
Researchers found a minuscule enzyme that could help advance gene-editing therapy. The National Institutes of Health (NIH) announced the discovery of an enhanced gene-editing system, which can deliver…
Read More